Carla-Sophie Imperadeiro

Partner

Paris
carla-sophie.imperadeiro@lw.com
+33.1.40.62.29.31

PRACTICES

  • Banking

BAR QUALIFICATIONS

  • Avocat (Paris)

EDUCATION

  • Postgraduate Degree Law and Economic Globalization, Institut d’Études Politiques de Paris, 2006
  • Postgraduate Degree International Trade Law (DEA), University of Paris I (Pantheon-Sorbonne), 2005
  • Graduate Degree Business Law, University of Paris I (Pantheon-Sorbonne), 2004

LANGUAGES SPOKEN

  • French
  • English
  • Portuguese

PROFILE

Carla-Sophie Imperadeiro is a partner in Latham & Watkins' Finance Department. She has a wide range of experience representing borrowers, equity sponsors, and lead banks in financing transactions, with a particular emphasis in private equity and LBO financings.

Carla-Sophie received her graduate business law and postgraduate international trade law degrees at the University of Paris, Pantheon-Sorbonne in 2004 and 2005, respectively. She received her postgraduate law degree from the Institut d’Etudes Politiques de Paris in 2006.

EXPERIENCE

Carla-Sophie's recent experience includes representing:

  • Bridgepoint in its acquisition of LumApps
  • The banks in connection with Kapla Holding’s liability management exercise and offering of €650 million senior secured floating rate notes
  • Eurazeo on its contemplated sale of D.O.R.C. for an enterprise value of €985 million
  • PAI Partners in its majority investment in ECF Group
  • Vivalto Santé, the third leading group of private hospitals in France, in its acquisition by Vivalto Partners alongside a consortium of minority shareholders
  • SK Capital in its acquisition of SEQENS
  • Astorg in connection with the financing of the acquisition of Solina, the leading European manufacturer of ingredient and seasoning blends for the food industry from Ardian
  • Bridgepoint, Summit Partners, and Calypso Technology in connection with the financing of the acquisition of Calypso, a cloud-enabled provider of cross-asset front-to-back solutions and managed services for financial markets, by Thoma Bravo
  • Ardian in connection with the:
    • Sale of its majority stake in Unither Pharmaceuticals (Unither), a global leader in the development and manufacturing of sterile unit-doses
    • Financing of the acquisition of a minority stake in Inovie, the leading independent medical diagnostic provider in France
    • Sale of its majority stake of Kersia, a global leader in biosecurity and food safety to IK Investment Partners
  • The banks in connection with the financing of the acquisition of Conforama France, the French furniture retailer, by the shareholders of But
  • Kersia Group, a portfolio company of Ardian, in connection with the financing of the acquisition of The Holchem Group Limited and its subsidiaries from Ecolab
  • Cobepa in connection with the sale of its Stake in Staci, a logistics solutions provider for companies, to Ardian